Effect of Teduglutide on Gastric Emptying in Healthy Subjects

NCT01209351 ↗

Phase 1 Completed 36 enrolled Shire

RandomizedParallel-groupDouble-blindOther

Summary

The primary objective of this study is to assess the effects of 10 consecutive, daily, subcutaneous doses of 4 mg of teduglutide as compared with placebo on gastric emptying as assessed by acetaminophen absorption kinetics in healthy subjects.

Timeline

Start: 2010-09-28
Primary completion: 2010-11-08
Completion: 2010-11-08

Publications

Berg JK, Kim EH, Li B, Joelsson B, Youssef NN. A randomized, double-blind, placebo-controlled, multiple-dose, parallel-group clinical trial to assess the effects of teduglutide on gastric emptying of liquids in healthy subjects. BMC Gastroenterol. 2014 Feb 12;14:25. doi: 10.1186/1471-230X-14-25.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Teduglutide	Peptide	4 mg	Subcutaneous

Indications

No indication recorded.